Two new studies have been undertaken to further explore the safety and efficacy of ForsLean®, Sabinsa’s patented lean body mass promoting and weight loss...Read More
Latest Press Releases
ForsLean addresses overall metabolic health and not just weight management, says Mr. Shaheen Majeed, President-Worldwide, Sabinsa
May 2, 2019
At April’s SupplySide East trade show, Sabinsa Corp. (East Windsor, NJ) explained how its branded Coleus forskohlii extract ingredient, ForsLean, is approaching the weight management.
Sabinsa Awarded New Patents For ForsLean®: New Scientific Discoveries Warrant Energy Balance Claims
April 4, 2019
Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Process and compositions for.
Sabinsa Publishes ForsLean® Safety Data in International Journal of Pharmacy & Pharmaceutical Research
January 19, 2016
Sabinsa Corporation and Sami Labs founder Dr. Muhammed Majeed was lead author of a paper published on the cumulative safety data of ForsLean®, the company’s.
In an effort to assist their customers, and potential customers, to understand the scope of Patent # 5,804,596, Sabinsa Corporation requested its legal counsel,...Read More
Sabinsa Corporation announces that its popular dietary supplement ingredient ForsLean®, a standardized extract from Coleus forskholii roots patented by Sabinsa...Read More